Biography and Research Information
OverviewAI-generated summary
Monica Graziutti's research focuses on multiple myeloma, particularly in the context of hematopoietic stem cell transplantation. She has investigated salvage autologous stem cell transplantation for patients with daratumumab-refractory multiple myeloma and examined the feasibility of outpatient stem cell transplantation, identifying risk factors for hospital admission. Her work also includes exploring tandem autologous stem cell transplantation for patients with persistent minimal residual disease in the bone marrow after an initial transplantation. Graziutti has collaborated with Sharmilan Thanendrarajan, Maurizio Zangari, Sravani Gundarlapalli, and Guido Tricot on multiple publications within the University of Arkansas for Medical Sciences. Her scholarship metrics include an h-index of 4, with a total of 4 publications and 47 citations.
Metrics
- h-index: 4
- Publications: 4
- Citations: 47
Selected Publications
-
Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission (2022)
-
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma (2022)
-
Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma (2021)
Collaboration Network
Top Collaborators
Lakshmi Yarlagadda
University of Arkansas for Medical Sciences (US)
3 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
Sravani Gundarlapalli
University of Arkansas for Medical Sciences
3 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
Yetunde Ogunsesan
University of Arkansas for Medical Sciences (US)
3 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
Sharmilan Thanendrarajan
University of Arkansas for Medical Sciences
3 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
Meera Mohan
Medical College of Wisconsin (US)
3 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
Maurizio Zangari
University of Arkansas for Medical Sciences
3 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
Frits van Rhee
University of Arkansas for Medical Sciences
3 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
Carolina Schinke
University of Arkansas for Medical Sciences
3 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
Richa Parikh
University of Arkansas for Medical Sciences (US)
2 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
Mathew Kottarathara
University of Arkansas for Medical Sciences (US)
2 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
Shadiqul Hoque
University of Arkansas for Medical Sciences (US)
2 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
Angel Mitma
University of Arkansas for Medical Sciences (US)
2 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
Clyde Bailey
University of Arkansas for Medical Sciences
2 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
Kerri Hill
University of Arkansas for Medical Sciences
2 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
Guido Tricot
University of Arkansas for Medical Sciences
2 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
Similar Researchers
Based on overlapping research topics
Bart Barlogie
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology
O. Makhoul
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology
Munawar Hussain .
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology
Mattie R Nester
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Receptor Mechanisms and Signaling
Naveen Yarlagadda
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology
Kerri Hill
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology